Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • Burning Rock Biotech's Cash from Operations rose 11451.81% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year increase of 7337.5%. This contributed to the annual value of -$12.6 million for FY2024, which is 6491.42% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Cash from Operations of $2.3 million as of Q3 2025, which was up 11451.81% from -$9.5 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Cash from Operations registered a high of $2.6 million during Q4 2024, and its lowest value of -$66.2 million during Q4 2022.
  • Moreover, its 5-year median value for Cash from Operations was -$15.9 million (2024), whereas its average is -$14.2 million.
  • In the last 5 years, Burning Rock Biotech's Cash from Operations plummeted by 31304.9% in 2021 and then skyrocketed by 21573.58% in 2024.
  • Burning Rock Biotech's Cash from Operations (Quarter) stood at -$17.6 million in 2021, then plummeted by 275.71% to -$66.2 million in 2022, then surged by 96.59% to -$2.3 million in 2023, then soared by 215.74% to $2.6 million in 2024, then decreased by 11.8% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, -$9.5 million for Q2 2025, and -$3.2 million during Q1 2025.